Biotechnology
Italian companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Moderna, Inc. ranks as the top gainer, and Arterra Bioscience SpA sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 4AMGNAmgen Inc. | 230.4 B EUR | 413.60 EUR | −0.96% | 0 | 0.00 | 27.18 | 15.22 EUR | +38.07% | 2.08% | Health technology | Neutral |
 4GILDGilead Sciences, Inc. | 192.75 B EUR | 150.38 EUR | −2.01% | 0 | — | — | −2.78 EUR | −150.52% | 1.86% | Health technology | Buy |
 4MRNAModerna, Inc. | 91.88 B EUR | 236.10 EUR | +7.42% | 210 | 6.05 | — | −6.99 EUR | −9.55% | 0.00% | Health technology | Neutral |
 4BMRNBioMarin Pharmaceutical Inc. | 9.86 B EUR | 50.06 EUR | −1.61% | 0 | — | — | −0.09 EUR | −104.02% | 0.00% | Health technology | Buy |
 4LKFTLakefront Biotherapeutics | 1.96 B EUR | 29.76 EUR | −2.04% | 0 | — | 3.29 | 9.05 EUR | — | 0.00% | Health technology | Buy |
 4VLAValneva SE | 481.73 M EUR | 2.504 EUR | −2.34% | 0 | — | — | −0.90 EUR | −117.39% | 0.00% | Health technology | Strong buy |
 ARBSArterra Bioscience SpA | 20.04 M EUR | 3.02 EUR | 0.00% | 1.5 K | 0.49 | 12.09 | 0.25 EUR | −12.69% | 4.98% | Health technology | No rating |